Suchergebnisse - "Liang, Xuan"

PubPharm (7)

1

The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases

enthalten in: International journal of molecular sciences | 2023

von Liang, X. | Dai, Z. | Zou, R. | +2

2

PDK2 induces cisplatin-resistance in lung adenocarcinoma via transcriptional regulation of CNNM3

enthalten in: Journal of drug targeting | 2019

von Hu, T. | Yu, S. | Li, Y. | +5

3

Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway

enthalten in: Oxidative medicine and cellular longevity | 2019

von Huang, T. | Zhou, F. | Yuan, X. | +7

4

HOXA4-Dependent Transcriptional Activation of AXL Promotes Cisplatin- Resistance in Lung Adenocarcinoma Cells

enthalten in: Anti-cancer agents in medicinal chemistry | 2018

von Yu, S. | Ren, H. | Li, Y. | +5

5

Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase

enthalten in: Molecular medicine reports | 2016

von Guo, Q. | Liu, Z. | Jiang, L. | +6

6

In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell lines

enthalten in: Oncology reports | 2015

von Wang, M. | Liang, X. | Liu, Z. | +12

7

Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway

enthalten in: Drug design, development and therapy | 2015

von Wu, T. | Wang, M. | Jing, L. | +7

1
[1]